Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients-Reference-Cited by-同舟云学术

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

Published:2011-11-02 Issue:11 Volume:187 Page:6130-6142
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Alfaro Carlos,Perez-Gracia Jose L.,Suarez Natalia,Rodriguez Javier,Fernandez de Sanmamed Miguel,Sangro Bruno,Martin-Algarra Salvador,Calvo Alfonso,Redrado Miriam,Agliano Alice,Gonzalez Alvaro,Rodriguez Inmaculada,Bolaños Elixabet,Hervás-Stubbs Sandra,Perez-Calvo Javier,Benito Alberto,Peñuelas Ivan,Vigil Carmen,Richter José,Martinez-Forero Ivan,Melero Ignacio

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. Cancer Immunotherapy by Dendritic Cells

2. Recent Developments in Cancer Vaccines

3. DC-based cancer vaccines

4. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.;Su;Cancer Res.,2003

5. Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy;Pathology - Research and Practice;2024-01

2. Colorectal Cancer Immunotherapy: State of the Art and Future Directions;Gastro Hep Advances;2023

3. Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial;Frontiers in Immunology;2021-11-11

4. Pleural mesothelioma (PM) – The status of systemic therapy;Cancer Treatment Reviews;2021-11

5. Inhibition of topoisomerase I shapes antitumor immunity through the induction of monocyte-derived dendritic cells;Cancer Letters;2021-11